Question to the Department of Health and Social Care:

To ask Her Majesty's Government what assessment they have made of the potential use of ivermectin to treat COVID-19 patients; and what bodies were involved in any such assessment.

The Therapeutics Taskforce is monitoring data from clinical trials taking place worldwide to assess whether ivermectin is a safe and effective treatment for COVID-19. Ivermectin is not currently a licensed treatment for COVID-19 and evidence from clinical trials as a treatment for COVID-19 is inconclusive. This assessment is based on the views of the Therapeutics Taskforce, the UK COVID-19 Therapeutics Advisory Panel and the Research to access pathway for investigational drugs for COVID-19. This assessment is also consistent with the views of the World Health Organization, the Food and Drug Administration and the European Medicines Agency. We will continue to keep this assessment under review as more data becomes available from clinical trials, including the Government-funded PRINCIPLE clinical trial.